uveitis/edema

UNASSIGNED To report the successful utilization of adjunctive repeat intravitreal corticosteroid therapy for the treatment of cystoid macular edema in syphilis-related uveitis. UNASSIGNED An HIV-positive patient with treated ocular syphilis who developed refractory cystoid macular edema (CME) was

The authors wish to report a case of bilateral acute anterior uveitis and optic disc edema following a hemotoxic snake bite, in order to highlight the concomitant occurrence of these conditions and the potential adverse effects of anti-snake venom (ASV). A 35-year-old male was bitten by a viper at

OBJECTIVE To investigate the adverse ocular effects of intravitreal ketorolac (4 mg) in patients with chronic uveitis and complications of chronic inflammation (macular edema). METHODS We conducted a prospective phase 1 clinical trial involving 10 eyes of 10 adult patients with chronic inflammation

A 13-year-old boy with a 4-year history of idiopathic pediatric uveitis and recurrent uveitic macular edema had failed conventional immunomodulatory therapy and presented to us with a vision of 6/24 [right eye (OD)] and 6/9 [left eye (OS)]. Fluorescein angiography showed diffuse vascular leakage

OBJECTIVE To report on the efficacy of the somatostatin analog octreotide long-acting repeatable (LAR), in the treatment of uveitic chronic macular edema (CME). METHODS Case series, retrospective analysis. METHODS In 20 patients, 20 episodes of recurrent CME during otherwise quiescent uveitis were

OBJECTIVE To describe progression and resolution of uveitis-associated cystoid macular edema (uvCME) using spectral-domain optical coherence tomography and find predictive factors for successful intravitreal triamcinolone acetonide (IVTA) therapy. METHODS Twenty-nine eyes with treatment-naive uvCME

OBJECTIVE This study aims to investigate the relationship between macular sensitivity and thickness in eyes with uveitic macular edema (UME). METHODS This study is a prospective observational case series. METHODS The setting for this study was clinical practice. The study included 59 (28 with UME,

OBJECTIVE To perform a prospective pilot study to evaluate interferon alfa-2a (IFN alfa-2a) for the treatment of refractory cystoid macular edema (CME) in endogenous uveitis. METHODS IFN alfa-2a was administered at an initial dose of 3 or 6 million IU (depending on body weight) per day

OBJECTIVE To evaluate the 2-year outcomes of uveitic macular edema. METHODS Longitudinal follow-up of a randomized cohort. METHODS At baseline, 148 eyes of 117 patients enrolled in the Multicenter Uveitis Steroid Treatment (MUST) Trial had macular edema, and 134 eyes of 108 patients completed 2-year

OBJECTIVE To study use of optical coherence tomography (OCT) for macular edema in uveitis. METHODS In total, 44 patients with uveitis and macular edema underwent OCT. Data obtained were correlated with anatomic type, duration of uveitis, and visual acuity (VA). RESULTS Both cystoid macular edema

Cystoid macular edema (CME) can cause profound visual loss and is one of the major causes of legal blindness in patients with uveitis. It can complicate virtually any type of acute or chronic, anterior or posterior uveitis. When mild and of short duration, CME may respond to treatment used to

OBJECTIVE To evaluate the macular volume in eyes with immune recovery uveitis (IRU) and to describe a new method to quantify macular edema with the use of confocal scanning laser tomography (cSLT). METHODS A prospective study was performed to assess the macular volume with cSLT in patients with and

OBJECTIVE To evaluate the use of intravitreal triamcinolone (IVTA) for the treatment of macular edema secondary to immune recovery uveitis (IRU) in patients with AIDS. METHODS Prospective, consecutive, interventional case series. METHODS Eight eyes of 7 patients receiving 13

OBJECTIVE To study the effect of acetazolamide on cystoid macular edema in patients with uveitis. METHODS Forty patients with chronic intermediate, posterior, or panuveitis associated cystoid macular edema were randomized into a masked, cross-over trial comparing acetazolamide versus placebo.